The latest research study “Antifibrinolytic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global antifibrinolytic drugs market reached a value of US$ 15.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 20.46 Billion by 2027, exhibiting a CAGR of 4.60% during 2022-2027.
Antihyperlipidemic drugs are used to lower serum levels of cholesterol in the blood. They are prescribed along with different medications to control the lipid level in the blood that can also lead to obesity, hypertension, diabetes, and hyperlipidemia. These drugs also assist in increasing the high-density lipoprotein cholesterol in the body and preventing coronary heart conditions. Some of the commonly available antihyperlipidemic drugs include bile acid sequestrants, antihyperlipidemic agents, and cholesterol absorption inhibitors.
Request for a Free Sample Copy of This Report: https://www.imarcgroup.com/antifibrinolytic-drugs-market/requestsample
Antifibrinolytic Drugs Market Trends:
The market is primarily driven by the rising cases of hyperlipidemia among individuals due to sedentary lifestyles, obesity, and consumption of fast foods. Additionally, the increasing geriatric population that is more susceptible to developing cardiovascular diseases represents another major growth-inducing factor.
Besides this, the growing prevalence of genetic, and acquired lipid and lipoprotein metabolism disorders among the pediatric population is further escalating the demand for antihyperlipidemic drugs to reduce hospitalization rates and premature deaths. Furthermore, the growing awareness regarding complications related to hyperlipidemia is also propelling the market growth.
Antifibrinolytic Drugs Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Major Players Covered:
- ACIC Pharmaceuticals Inc.
- Akorn Inc.
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Viatris Inc.
- Aurobindo Pharma Limited
- Ferring Pharmaceuticals
- Novartis AG
- Vitruvias Therapeutics Inc.
Key Market Segmentation:
The report has segmented the market on the basis of indication, form, end user and region.
Breakup by Indication:
- Gynecology
- Hereditary Angioedema
- Fibrinolytic Response Testing
- Surgeries
- Others
Breakup by Form:
- Oral
- Injectable
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Trauma Centers
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Click here to view detailed information with table of content: https://bit.ly/3zeCbfK
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St.
City: Brooklyn
State: NY
Country: United States
Browse More: Specialty Insurance Market Growth, Trends and Global Size Report 2022 to 2027
